Smoking Cessation in Individuals With Serious Mental Illness: A Randomized Controlled Trial of Two Psychosocial Interventions

REFERENCES

• Addington, J. (1998). Group treatment for smoking cessation among persons with schizophrenia. Psychiatric Services, 49, 925–928.
   PubMed Web of Science ®Google Scholar
• Auquier, P., Lancon, C., Rouillon, F., Lader, M., & Holmes, C. (2006). Mortality in schizophrenia. Pharmacoepidemiology and Drug Safety, 15(12), 873–879.
   PubMed Web of Science ®Google Scholar
• Baker, A., Richmond, R., Haile, M., Lewin, T.J., Carr, V.J., Taylor, R.L., … & Wilhelm, K. (2006). A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 1934–1942.
   PubMed Web of Science ®Google Scholar
• Bedfont Scientific U. (n.d.). EC50 Micro III Smokerlyzer Breath Carbon Monoxide Monitor. Medford: Bedfont Scientific Ltd Ed.
   Google Scholar
• Bellack, A.S., Bennett, M.E., Gearon, J.S, Brown, C.H., & Yang, Y. (2006). A randomized clinical trial of a new behavioral intervention for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry, 63, 426–432.
   PubMed Web of Science ®Google Scholar
• Bennett, M.E., Bellack, A.S., & Gearon, J.S. (2001). Treating substance abuse in schizophrenia: An initial report. Journal of Substance Abuse Treatment, 20, 163–175.
   PubMed Web of Science ®Google Scholar
• Bennett, M.E., Dixon, L., & Dickerson, F. (2008, November). Behavioral treatment for smoking cessation in serious and persistent mental illness. Presented at the 42nd annual meeting of the Association for the Advancement of Behavioral and Cognitive Therapies, Orlando, Florida.
   Google Scholar
• Bennett, M.E., Wilson, A.L., Genderson, M., & Saperstein, A.M. (2013). Smoking cessation in people with schizophrenia. Current Drug Abuse Reviews, 6(3), 180–190.
   PubMedGoogle Scholar
• Bickel, W.K., Amass, L., Higgins, S.T., Badger, G.J., & Esch, R.A. (1997). Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology, 65, 803–810.
   PubMed Web of Science ®Google Scholar
• Brunette, M.F., Ferron, J.C., McHugo, G.J., Davis, K.E., Devitt, T.S., Wilkness, S.M., & Drake, R.E. (2011). An electronic decision support system to motivate people with severe mental illnesses to quit smoking. Psychiatric Services, 62(4), 360–366. doi:10.1176/appi.ps.62.4.360
   PubMed Web of Science ®Google Scholar
• Buchanan, R.W., Kreyenbuhl, J., Kelly, D.L., Noel, J.M., Boggs, D.L., Fischer, B.A., … Keller, W. (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 71–93. doi:10.1093/schbul/sbp116
   PubMed Web of Science ®Google Scholar
• Bushe, C.J., Taylor, M., & Haukka, J. (2010). Mortality in schizophrenia: A measurable clinical endpoint. Journal of Psychopharmacology, 24(4 supplement), 17–25. doi:10.1177/1359786810382468
   PubMed Web of Science ®Google Scholar
• Carney, C.P., & Jones, L.E. (2006). Medical comorbidity in women and men with bipolar disorders: A population-based controlled study. Psychosomatic Medicine, 68(5), 684–691.
   PubMed Web of Science ®Google Scholar
• Carney, C.P., Jones, L., & Woolson, R.F. (2006). Medical comorbidity in women and men with schizophrenia: A population-based controlled study. Journal of General Internal Medicine, 21(11), 1133–1137.
   PubMed Web of Science ®Google Scholar
• Cather, C., Dyer, M.A., Burrell, H.A., Hoeppner, B., Goff, D.C., & Evins, E.A. (2013). An open trial of relapse prevention therapy for smokers with schizophrenia. Journal of Dual Diagnosis, 9(1), 87–93. doi:10.1080/15504263.2012.749559
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2014). Best Practices for Comprehensive Tobacco Control Programs–2014. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
   Google Scholar
• Compton, M.T., Daumit, G.L., & Druss, B.G. (2006). Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: A preventive perspective. Harvard Review of Psychiatry, 14(4), 212–222.
   PubMed Web of Science ®Google Scholar
• Currie, S.R., Karltyn, J., Lussier, D., de Denus, E., Brown, D., & El-Guebaly, N. (2008). Outcome from a community-based smoking cessation program for persons with serious mental illness. Community Mental Health Journal, 44(3), 187–194.
   PubMed Web of Science ®Google Scholar
• Deegan, P.E., & Drake, R.E. (2006). Shared decision making and medication management in the recovery process. Psychiatric Services, 57, 1636–1639.
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services, National Center for Health Statistics. (1998). The Third National Health and Nutrition Examination Survey 1988-94 (NHANES III). Hyattsville, MD: Center for Disease Control and Prevention.
   Google Scholar
• Department of Veterans Affairs, Veterans Health Administration. (2012). VHA DIRECTIVE 2012-002: Re-Engaging Veterans with Serious Mental Illness in Treatment. Washington, DC.
   Google Scholar
• Dickerson, F., Bennett, M., Dixon, L., Burke, E., Vaughan, C., Delahanty, J., & DiClemente, C. (2011). Smoking cessation in persons with serious mental illness: The experience of successful quitters. Psychiatric Rehabilitation Journal, 34(4), 311–316. doi:10.2975/34.4.2011.311.316
   PubMed Web of Science ®Google Scholar
• Dickerson, F., Stallings, C., Origoni, A., Schroeder, J., Khushalani, S., & Yolken, R. (2013). Mortality in schizophrenia: Clinical and serological predictors. Schizophrenia Bulletin, 40(4), 796–803. doi:10.1093/schbul/sbt113
   PubMed Web of Science ®Google Scholar
• Dickerson, F., Stallings, C.R., Origoni, A.E., Vaughan, C., Khushalani, S., Schroeder, J., & Yolk, R.H. (2013). Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999–2011. Psychiatric Services, 64(1), 44–50. doi:10.1176/appi.ps.201200143
   PubMed Web of Science ®Google Scholar
• DiClemente, C.C., Prochaska, J.O., & Gibertinin, M. (1985). Self-efficacy and the stages of self-change of smoking. Cognitive Therapy and Research, 9, 181–200.
   Web of Science ®Google Scholar
• Dixon, L., Dickerson, F., Bellack, A., Bennett, M., Dickinson, D., Goldberg, R., … Kreyenbuhl, J. (2010). The 2009 PORT psychosocial treatment recommendations and summary statement. Schizophrenia Bulletin, 36(1), 48–70. doi:10.1093/schbul/sbp115
   PubMed Web of Science ®Google Scholar
• Dixon, L., Medoff, D.R., Wohlheiter, K., DiClemente, C., Goldberg, R., Kreyenbuhl, J., … Davin, C. (2007). Correlates of severity of smoking among persons with severe mental illness. American Journal on Addictions, 16(2), 101–110.
   PubMed Web of Science ®Google Scholar
• Drake, R.E., Mueser, K.T., & Brunette, M.F. (2007). Management of persons with co-occurring severe mental illness and substance use disorder: Program implications. World Psychiatry, 6(3), 131–136.
   PubMed Web of Science ®Google Scholar
• Duffy, S.A., Kilbourne, A.M., Austin, K.L., Dalack, G.W., Woltmann, E.M., Waxmonsky, J., & Noonan, D. (2012). Risk of smoking and receipt of cessation services among veterans with mental disorders. Psychiatric Services, 63(4), 325–332. doi:10.1176/appi.ps.201100097
   PubMed Web of Science ®Google Scholar
• Epstein, D.H., Hawkins, W.E., Covi, L., Umbricht, A., & Preston, K.L. (2003). Cognitive-behavioral therapy plus contingency management for cocaine use: Findings during treatment and across 12-month follow-up. Psychology of Addictive Behaviors, 17, 73–82.
   PubMed Web of Science ®Google Scholar
• Esterberg, M.L., & Compton, M.T. (2005). Smoking behavior in persons with a schizophrenia-spectrum disorder: A qualitative investigation of the transtheoretical model. Social Science and Medicine, 61(2), 293–303.
   PubMed Web of Science ®Google Scholar
• Evins, A.E., Cather, C., & Laffer, A. (2015). Treatment of tobacco use disorder in smokers with serious mental illness: Toward clinical best practices. Harvard Review of Psychiatry, 23(2), 90–98. doi:10.1097/HRP.0000000000000063
   PubMed Web of Science ®Google Scholar
• Evins, A.E., Cather, C., Pratt, S.A., Pachas, G.N., Hoeppner, S.S., Goff, D.C., … Schoenfeld, D.A. (2014). Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial. JAMA: The Journal of the American Medical Association, 311(2), 145–154. doi:10.1001/jama.2013.285113
   PubMed Web of Science ®Google Scholar
• Ferron, J.C., Alterman, A., McHugo, G.J., Brunette, M.F., & Drake, R.E. (2009). A review of research on smoking cessation interventions for adults with schizophrenia spectrum disorders. Mental Health and Substance Abuse: Dual Diagnosis, 2(1), 64–79. doi:10.1080/17523280802593327
   Google Scholar
• Fiore, M.C., Jaen, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J., … Wewers, M.E. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. Retrieved from http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/update/treating_tobacco_use08.pdf
   Google Scholar
• George, T.P., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J., … Kosten, T.R. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.
   PubMed Web of Science ®Google Scholar
• Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerström, K.O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström tolerance questionnaire. British Journal of Addictions, 86, 1119–1127.
   PubMedGoogle Scholar
• Hennekens, C.H., Hennekens, A.R., Hollar, D., & Casey, D.E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115–1121.
   PubMed Web of Science ®Google Scholar
• Himelhoch, S., & Daumit, G. (2003). To whom do psychiatrists offer smoking-cessation counseling?. American Journal of Psychiatry, 160, 2228–2230.
   PubMed Web of Science ®Google Scholar
• Himelhoch, S., Lehman, A., Kreyenbuhl, J., Daumit, G., Brown, C, & Dixon, L. (2004). Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. American Journal of Psychiatry, 161, 2317–2319.
   PubMed Web of Science ®Google Scholar
• Himelhoch, S., Riddle, J., & Goldman, H.H. (2014). Barriers to implementing evidence-based smoking cessation practices in nine community mental health sites. Psychiatric Services, 65(1), 75–80. doi:10.1176/appi.ps.201200247
   PubMed Web of Science ®Google Scholar
• Jeste, D.V., Gladsjo, J.A., Lindamer, L.A., & Lacro, J.P. (1996). Medical comorbidity in schizophrenia. Schizophrenia Bulletin, 22(3), 413–430.
   PubMed Web of Science ®Google Scholar
• Kelly, D.L., McMahon, R.P., Liu, F., Love, R.C., Wehring, H.J., Shim, J.C., … Conley, R.R. (2010). Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: A retrospective cohort study. Journal of Clinical Psychiatry, 71, 304–311. doi:10.4088/JCP.08m04718yel
   PubMed Web of Science ®Google Scholar
• Kelly, D.L., Raley, H., Lo, S., Wright, K., Moolchan, E., Feldman, S., … Heishman, S. (2012). Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophrenia Bulletin, 38, 543–551. doi:10.1093/schbul/sbq124
   PubMed Web of Science ®Google Scholar
• Kelly, D.L., Wehring, H.J., Linthicum, J., Feldman, S., McMahon, R.P., Love, R.C., … Fowler, D.R. (2009). Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone. Schizophrenia Research, 107, 134–138. doi:10.1016/j.schres.2008
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl, J., Nossel, I.R., & Dixon, L.B. (2009). Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: A review of the literature. Schizophrenia Bulletin, 35(4), 696–703. doi:10.1093/schbul/sbp046.
   PubMed Web of Science ®Google Scholar
• Lawn, S., & Campion, J. (2013). Achieving smoke-free mental health services: Lessons from the past decade of implementation research. International Journal of Environmental Research and Public Health, 10, 4224–4244. doi:10.3390/ijerph10094224
   PubMed Web of Science ®Google Scholar
• Leonard, S., & Adams, C.E. (2006). Smoking cessation and schizophrenia. American Journal of Psychiatry, 163 (11), 1877.
   PubMed Web of Science ®Google Scholar
• Little, R.J. A., & Rubin, D.B. (2002). Statistical analysis with missing data, 2nd ed. Hoboken, NJ: Wiley.
   Google Scholar
• Lucksted, A., Dixon, L.B., & Sembly, J.B. (2000). A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatric Services, 51, 1544–1548.
   PubMed Web of Science ®Google Scholar
• Mann-Wrobel, M.C., Bennett, M.E., Weiner, E.E., Buchanan, R.W., & Ball, M.P. (2010). Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. Schizophrenia Research, 126(1–3), 277–283. doi:10.1016/j.schres.2010.10.030
   PubMed Web of Science ®Google Scholar
• Miller, B.J., Paschall, C.B., & Svendsen, D.P. (2006). Mortality and medical comorbidity among patients with serious mental illness. Psychiatric Services, 57(1), 1482–1487.
   PubMed Web of Science ®Google Scholar
• Moore, D., Aveyard, P., Connock, M., Wang, D., Fry-Smith, A., & Barton, P. (2009). Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. British Medical Journal, 338, 1024. doi:10.1136/bmj.b1024.
   PubMed Web of Science ®Google Scholar
• Muir-Cochrane, E. (2006). Medical comorbidity risk factors and barriers to care for people with schizophrenia. Journal of Psychiatric Mental Health Nursing, 13(4), 447–452.
   PubMed Web of Science ®Google Scholar
• Newcomer, J.W. (2006). Medical risk in patients with bipolar disorder and schizophrenia. Journal of Clinical Psychiatry, 67(11), e16.
   PubMedGoogle Scholar
• Overall, J.E., & Gorham, D.R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799–812.
   Web of Science ®Google Scholar
• Prochaska, J.J. (2010a). Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug and Alcohol Dependence, 110(3), 177–182. doi: 0.1016/j.drugalcdep.2010.03.002
   PubMed Web of Science ®Google Scholar
• Prochaska, J.J. (2010b). Integrating tobacco treatment into mental health settings. JAMA: The Journal of the American Medical Association, 304(22), 2534–2535. doi:10.1001/jama.2010.1759
   PubMed Web of Science ®Google Scholar
• Ratschen, E., Britton, J., & McNeill, A. (2011). The smoking culture in psychiatry: Time for change. British Journal of Psychiatry, 198, 6–7. doi:10.1192/bjp.bp.110.081372
   PubMed Web of Science ®Google Scholar
• Selzer, M.L. (1971). The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. American Journal of Psychiatry, 127, 1653–1658.
   PubMed Web of Science ®Google Scholar
• Shim, J.C., Jung, D.U., Jung, S.S., Seo, Y.S., Cho, D.M., Lee, J.H., … Kelly, D.L. (2012). Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: A randomized double-blind placebo-controlled trial. Neuropsychopharmacology, 37(3), 660–668. doi:10.1038/npp.2011.238
   PubMed Web of Science ®Google Scholar
• Sigmon, S.C., & Patrick, M.E. (2012). The use of financial incentives in promoting smoking cessation. Preventative Medicine, 55(Suppl), S24–S32. doi:10.1016/j.ypmed.2012.04.007
   Google Scholar
• Skinner, H. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7, 363–371.
   PubMed Web of Science ®Google Scholar
• Smith, P.H., Mazure, C.M., & McKee, S.A. (2014). Smoking and mental illness in the U.S. population. Tobacco Control, 23, 147–153. doi:10.1136/tobaccocontrol-2013-051466
   PubMed Web of Science ®Google Scholar
• Sokal, J., Messias, E., Dickeron, F.B., Kreyenbuhl, J., Brown, C.H., Goldberg, R.W., & Dixon, L.B. (2004). Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. Journal of Nervous and Mental Disease, 192, 421–427.
   PubMed Web of Science ®Google Scholar
• Stitzer, M.L. (1999). Combined behavioral and pharmacological treatments for SC. Nicotine and Tobacco Research, 1(Suppl 2), S181–187.
   PubMedGoogle Scholar
• Tsoi, D.T., Porwal, M., & Webster, A.C. (2013a). Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews, 2, CD007253. doi:10.1002/14651858.CD007253
   PubMedGoogle Scholar
• Tsoi, D.T., Porwal, M., & Webster, A.C. (2013b). Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: Systematic review and meta-analysis. British Journal of Psychiatry, 196(5), 346–353. doi:10.1192/bjp.bp.109.066019
   Web of Science ®Google Scholar
• Weiner, E., Ball, M.P., Summerfelt, A., Gold, J., & Buchanan, R.W. (2001). Effects of sustained-release bupropion and supportive group therapy on cigarette smoking in patients with schizophrenia. American Journal of Psychiatry, 158(4), 635–637.
   PubMed Web of Science ®Google Scholar
• Williams, J.M., Anthenelli, R.M., Morris, C.D., Treadow, J., Thompson, J.R., Yunis, C., & George, T.P. (2012). A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry, 73(5), 654–660. doi:10.4088/JCP.11m07522
   PubMed Web of Science ®Google Scholar
• Williams, J.M., Steinberg, M.L., Griffiths, K.G., & Cooperman, N. (2013). Smokers with behavioral health comorbidity should be designated a Tobacco Use Disparity Group. American Journal of Public Health, 103, 1549–1555. doi:10.2105/AJPH.2013.301232
   PubMed Web of Science ®Google Scholar
• Williams, J.M., Steinberg, M.L., Zimmermann, M.H., Gandhi, K.K., Stipelman, B., Budsock, P.D., & Ziedonis, D.M. (2010). Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. Journal of Substance Abuse Treatment, 38(4), 384–393. doi:10.1016/j.jsat.2010.03.006
   PubMed Web of Science ®Google Scholar
• Ziedonis, D.M., & George, T.P. (1997). Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin, 23, 247–254.
   PubMed Web of Science ®Google Scholar
• Ziedonis, D., Hitsman, B., Beckham, J.C., Zvolensky, M., Adler, L.E., Audrain-McGovern, J., … Riley, W.T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research, 10(12), 1691–1715. doi:10.1080/14622200802443569
   PubMed Web of Science ®Google Scholar